Together, our findings indicate that ATF4-ZEB1-E-cadherin axis is critical for HER2-mediated cell migration and that targeting of ATF4-ZEB1 may be a potential therapeutic strategy for HER2-mediated tumor metastasis. The gene discussed is ZEB1; the disease is neoplasm.